{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:06:35Z","timestamp":1781777195566,"version":"3.54.5"},"reference-count":17,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.1272\/jnms.jnms.2019_86-407","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T17:04:19Z","timestamp":1575306259000},"page":"258-262","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Alleviates Carbon Tetrachloride-Induced Liver Fibrosis in Mice"],"prefix":"10.1272","volume":"86","author":[{"given":"Jie","family":"Fu","sequence":"first","affiliation":[{"name":"Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, 2001 of Jingwei Building, The Second Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Du","sequence":"additional","affiliation":[{"name":"Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, 2001 of Jingwei Building, The Second Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, 2001 of Jingwei Building, The Second Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xundi","family":"Xu","sequence":"additional","affiliation":[{"name":"Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, 2001 of Jingwei Building, The Second Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669.","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG: Galpha12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 2018; 68: 493-504.","DOI":"10.1016\/j.jhep.2017.10.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dong M, Wu J, Yu X, Li J, Yang S, Qi X, Mao R, Zhang Y, Yu J, Zhu H, Yang F, Qin Y, Zhang J: Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver Int 2018; 38: 1562-1570.","DOI":"10.1111\/liv.13688"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Kaffe E, Katsifa A, Xylourgidis N, Ninou I, Zannikou M, Harokopos V, Foka P, Dimitriadis A, Evangelou K, Moulas AN, Georgopoulou U, Gorgoulis VG, Dalekos GN, Aidinis V: Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology 2017; 65: 1369-1383.","DOI":"10.1002\/hep.28973"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Higashi T, Friedman SL, Hoshida Y: Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017; 121: 27-42.","DOI":"10.1016\/j.addr.2017.05.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. White JP, Cibelli M, Urban L, Nilius B, McGeown JG, Nagy I: TRPV4: Molecular Conductor of a Diverse Orchestra. Physiol Rev 2016; 96: 911-973.","DOI":"10.1152\/physrev.00016.2015"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Szallasi YKaA: Transient receptor potential (TRP) channels: a clinical perspective. British Journal of Pharmacology 2014; 171: 2474-2507.","DOI":"10.1111\/bph.12414"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fang Y, Liu G, Xie C, Qian K, Lei X, Liu Q, Liu G, Cao Z, Fu J, Du H, Liu S, Huang S, Hu J, Xu X: Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway. Biomedicine & Pharmacotherapy 2018; 101: 910-919.","DOI":"10.1016\/j.biopha.2018.03.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hu Z, Cao X, Fang Y, Liu G, Xie C, Qian K, Lei X, Cao Z, Du H, Cheng X, Xu X: Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018; 105: 697-706.","DOI":"10.1016\/j.biopha.2018.06.029"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Seth RK, Das S, Dattaroy D, Chandrashekaran V, Alhasson F, Michelotti G, Nagarkatti M, Nagarkatti P, Diehl AM, Bell PD, Liedtke W, Chatterjee S: TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity. Free Radic Biol Med 2017; 102: 260-273.","DOI":"10.1016\/j.freeradbiomed.2016.11.047"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhan L, Yang Y, Ma TT, Huang C, Meng XM, Zhang L, Li J: Transient receptor potential vanilloid 4 inhibits rat HSC-T6 apoptosis through induction of autophagy. Mol Cell Biochem 2015; 402: 9-22.","DOI":"10.1007\/s11010-014-2298-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Song Y, Zhan L, Yu M, Huang C, Meng X, Ma T, Zhang L, Li J: TRPV4 channel inhibits TGF-beta1-induced proliferation of hepatic stellate cells. PLoS One 2014; 9: e101179.","DOI":"10.1371\/journal.pone.0101179"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Boehmerle W, Huehnchen P, Lee SLL, Harms C, Endres M: TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models. Exp Neurol 2018; 306: 64-75.","DOI":"10.1016\/j.expneurol.2018.04.014"},{"key":"14","unstructured":"14. Jie P, Tian Y, Hong Z, Li L, Zhou L, Chen L, Chen L: Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice. Front Cell Neurosci 2015; 9: 141."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC: NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 2017; 66: 1037-1046.","DOI":"10.1016\/j.jhep.2017.01.022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liu G, Xie C, Fang Y, Qian K, Liu Q, Liu G, Cao Z, Du H, Fu J, Xu X: Splenectomy after partial hepatectomy accelerates liver regeneration in mice by promoting tight junction formation via polarity protein Par 3-aPKC. Life Sci 2018; 192: 91-98.","DOI":"10.1016\/j.lfs.2017.11.032"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y: MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 2016; 7: 10993.","DOI":"10.1038\/ncomms10993"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/86\/5\/86_JNMS.2019_86-407\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T22:51:36Z","timestamp":1575672696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/86\/5\/86_JNMS.2019_86-407\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2019_86-407","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}